Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Doxycycline 100mg dispersible tablets sugar free
0501030Z0AAABAB
|
Doxycycline | Doxycycline monohydrate | Infections | 8,395 |
|
Carmellose 0.5% eye drops 0.4ml unit dose pf (Alissa)
21300000126
|
Carmellose 0.5% eye drops 0.4ml unit dose pf (Alissa) | Eye Products | Appliances | 8,393 |
|
VIZhyal 0.1% eye drops preservative free
21300000312
|
VIZhyal 0.1% eye drops preservative free | Eye Products | Appliances | 8,374 |
|
Maxitrol eye ointment
1104010I0BCABAF
|
Maxitrol | Dexamethasone | Eye | 8,371 |
|
Salicylic acid 16.7% / Lactic acid 16.7% paint
1307000M0AAAWAW
|
Salicylic acid (Warts/Calluses) | Salicylic acid | Skin | 8,371 |
|
Lisdexamfetamine 60mg capsules
0404000U0AAAEAE
|
Lisdexamfetamine | Lisdexamfetamine dimesylate | Central Nervous System | 8,343 |
|
Budesonide 200micrograms/dose dry powder inhaler
0302000K0AAAGAG
|
Budesonide (Inhalation) | Budesonide | Respiratory System | 8,328 |
|
Saflutan 15micrograms/ml eye drops 0.3ml unit dose
1106000AKBBAAAA
|
Saflutan | Tafluprost | Eye | 8,314 |
|
BioXtra Dry Mouth oral gel
21210000018
|
BioXtra Dry Mouth oral gel | Dry Mouth Products | Appliances | 8,312 |
|
Prazosin 500microgram tablets
0205040S0AAABAB
|
Prazosin hydrochloride | Prazosin hydrochloride | Cardiovascular System | 8,311 |
|
Fybogel Mebeverine effervescent granules sachets orange
0102000X0BCAAAA
|
Fybogel mebeverine | Mebeverine hydrochloride compound preparations | Gastro-Intestinal System | 8,310 |
|
Eicosapentaenoic acid 460mg/Docosahexaenoic acid 380mg caps
0212000ABAAAAAA
|
Omega-3-acid ethyl esters | Omega-3-acid ethyl esters | Cardiovascular System | 8,303 |
|
FML Liquifilm 0.1% ophthalmic suspension
1104010K0BBAAAA
|
FML | Fluorometholone | Eye | 8,287 |
|
Losartan 100mg / Hydrochlorothiazide 12.5mg tablets
0205052P0AAACAC
|
Losartan potassium/hydchlorothiazide | Losartan potassium with diuretic | Cardiovascular System | 8,287 |
|
Metoclopramide 5mg/5ml oral solution sugar free
0406000P0AAADAD
|
Metoclopramide hydrochloride | Metoclopramide hydrochloride | Central Nervous System | 8,287 |
|
Shortec 20mg capsules
0407020ADBJACAE
|
Shortec | Oxycodone hydrochloride | Central Nervous System | 8,281 |
|
Co-amilozide 2.5mg/25mg tablets
0202040C0AAABAB
|
Co-amilozide | Co-amilozide (Amiloride hydrochloride/hydrochlorothiazide) | Cardiovascular System | 8,275 |
|
Colecalciferol 4,000unit tablets
0906040G0AAEEEE
|
Colecalciferol | Colecalciferol | Nutrition and Blood | 8,274 |
|
Acti-Fast 2-way stretch stockinette 10.75cm
20090000497
|
Acti-Fast 2-way stretch stockinette 10.75cm | Stockinette | Dressings | 8,273 |
|
CliniFast stockinette 7.5cm
20090000939
|
CliniFast stockinette 7.5cm | Stockinette | Dressings | 8,271 |
|
Diltiazem 120mg modified-release capsules
0206020C0AAAUAU
|
Diltiazem hydrochloride | Diltiazem hydrochloride | Cardiovascular System | 8,263 |
|
Nutriprem 2 powder
0913111A0BBAAAA
|
Nutriprem powder preterm infant formula | Powder preterm infant formula (0913111) | Nutrition and Blood | 8,261 |
|
Lignospan Special 20mg/ml / 12.5micrograms/ml inj 2.2ml cart
1502010J0BTAACQ
|
Lignospan Special | Lidocaine hydrochloride | Anaesthesia | 8,234 |
|
Aquacel Extra dressing 10cm x 10cm square
20031700076
|
Aquacel Extra dressing 10cm x 10cm square | Wound Management & Other Dressings | Dressings | 8,213 |
|
Vascalpha 5mg modified-release tablets (Accord)
0206020F0BIAAAB
|
Vascalpha | Felodipine | Cardiovascular System | 8,213 |
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.